426 related articles for article (PubMed ID: 32397643)
1. Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.
Encinar JA; Menendez JA
Viruses; 2020 May; 12(5):. PubMed ID: 32397643
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
Chen Y; Su C; Ke M; Jin X; Xu L; Zhang Z; Wu A; Sun Y; Yang Z; Tien P; Ahola T; Liang Y; Liu X; Guo D
PLoS Pathog; 2011 Oct; 7(10):e1002294. PubMed ID: 22022266
[TBL] [Abstract][Full Text] [Related]
3. Binding of the Methyl Donor
Aouadi W; Blanjoie A; Vasseur JJ; Debart F; Canard B; Decroly E
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031370
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of RNA cap modification by SARS-CoV-2.
Viswanathan T; Arya S; Chan SH; Qi S; Dai N; Misra A; Park JG; Oladunni F; Kovalskyy D; Hromas RA; Martinez-Sobrido L; Gupta YK
Nat Commun; 2020 Jul; 11(1):3718. PubMed ID: 32709886
[TBL] [Abstract][Full Text] [Related]
5. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
Maurya SK; Maurya AK; Mishra N; Siddique HR
J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
[TBL] [Abstract][Full Text] [Related]
6. High-resolution structures of the SARS-CoV-2 2'-
Rosas-Lemus M; Minasov G; Shuvalova L; Inniss NL; Kiryukhina O; Brunzelle J; Satchell KJF
Sci Signal; 2020 Sep; 13(651):. PubMed ID: 32994211
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.
Wang Y; Sun Y; Wu A; Xu S; Pan R; Zeng C; Jin X; Ge X; Shi Z; Ahola T; Chen Y; Guo D
J Virol; 2015 Aug; 89(16):8416-27. PubMed ID: 26041293
[TBL] [Abstract][Full Text] [Related]
8. Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2.
Sharma K; Morla S; Goyal A; Kumar S
Life Sci; 2020 Oct; 259():118169. PubMed ID: 32738360
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16.
Klima M; Khalili Yazdi A; Li F; Chau I; Hajian T; Bolotokova A; Kaniskan HÜ; Han Y; Wang K; Li D; Luo M; Jin J; Boura E; Vedadi M
Protein Sci; 2022 Sep; 31(9):e4395. PubMed ID: 36040262
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.
Krafcikova P; Silhan J; Nencka R; Boura E
Nat Commun; 2020 Jul; 11(1):3717. PubMed ID: 32709887
[TBL] [Abstract][Full Text] [Related]
11. A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19.
Perveen S; Khalili Yazdi A; Devkota K; Li F; Ghiabi P; Hajian T; Loppnau P; Bolotokova A; Vedadi M
SLAS Discov; 2021 Jun; 26(5):620-627. PubMed ID: 33423577
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase.
Ahmed-Belkacem R; Sutto-Ortiz P; Guiraud M; Canard B; Vasseur JJ; Decroly E; Debart F
Eur J Med Chem; 2020 Sep; 201():112557. PubMed ID: 32563813
[TBL] [Abstract][Full Text] [Related]
13. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex.
Khalili Yazdi A; Li F; Devkota K; Perveen S; Ghiabi P; Hajian T; Bolotokova A; Vedadi M
SLAS Discov; 2021 Jul; 26(6):757-765. PubMed ID: 33874769
[TBL] [Abstract][Full Text] [Related]
14. Mn
Minasov G; Rosas-Lemus M; Shuvalova L; Inniss NL; Brunzelle JS; Daczkowski CM; Hoover P; Mesecar AD; Satchell KJF
Sci Signal; 2021 Jun; 14(689):. PubMed ID: 34131072
[TBL] [Abstract][Full Text] [Related]
15. Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase.
Benoni R; Krafcikova P; Baranowski MR; Kowalska J; Boura E; Cahová H
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578302
[TBL] [Abstract][Full Text] [Related]
16. Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM.
Sk MF; Jonniya NA; Roy R; Poddar S; Kar P
Front Mol Biosci; 2020; 7():590165. PubMed ID: 33330626
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Catalytic Mechanism of the RNA Cap Modification by nsp16-nsp10 Complex of SARS-CoV-2 through a QM/MM Approach.
Silva JRA; Urban J; Araújo E; Lameira J; Moliner V; Alves CN
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008724
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamic simulations reveal anti-SARS-CoV-2 activity of mitocurcumin by potentially blocking innate immune evasion proteins NSP3 and NSP16.
Pal D; Checker R; Kutala VK; Sandur SK
Mol Divers; 2023 Apr; 27(2):635-649. PubMed ID: 35538380
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus.
Jiang Y; Liu L; Manning M; Bonahoom M; Lotvola A; Yang Z; Yang ZQ
J Biomol Struct Dyn; 2022 Feb; 40(3):1331-1346. PubMed ID: 33016237
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of RNA cap methylation reveals different features of SARS-CoV-2 and SARS-CoV methyltransferases.
He M; Cao L; Liu L; Jin X; Zheng B; Liu X; Zhuang J; Zhang F; Yang Z; Ji Y; Xu T; Huang S; Chen J; Xie L; Li K; Hou P; Pan J; Guo D; Li C
J Med Virol; 2024 Feb; 96(2):e29411. PubMed ID: 38285434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
